Suchen Sie nach Informationen zu Hauptsitz Von Talecris Biotherapeutics? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://rocketreach.co/talecris-biotherapeutics-inc-profile_b5c5a19af42e0e7d
We are a biopharmaceutical company that is one of the largest producers and marketers of plasma-derived protein therapies in the world. We develop, produce, market, and distribute therapies that extend and enhance the lives of people suffering from chronic and acute, often life-threatening, conditions, such as chronic inflammatory demyelinating polyneuropathy (CIDP), …
https://www.bionity.com/en/companies/24418/talecris-biotherapeutics-gmbh.html
Talecris Continues Global Expansion into Europe. Talecris Biotherapeutics Inc. announced the establishment of Talecris Biotherapeutics GmbH, its European headquarters in Frankfurt, Germany. Europe represents the second expansion in 2006 for the North Carolina-based biotherapeutics manufacturer, completing the next regional phase in the co ...
https://www.crunchbase.com/organization/talecris-biotherapeutics
Founded Date 2004. Operating Status Closed. Stock Symbol NASDAQ:TLCR. Company Type For Profit. Phone Number 919-316-6300. Talecris Biotherapeutics is a biopharmaceutical company that produces and markets plasma-derived protein therapies. Talecris Biotherapeutics was founded in 2004 and is based in Barcelona, Spain.
https://www.linkedin.com/company/talecris-biotherapeutics-inc
Talecris Biotherapeutics, Inc. | 2,470 followers on LinkedIn. We are a biopharmaceutical company that is one of the largest producers and marketers of …
https://www.the-scientist.com/uncategorized/talecris-biotherapeutics-46623
Talecris BiotherapeuticsYou would be excused for supposing that Talecris Biotherapeutics, Inc., founded on April 1, 2005, is a young company. In truth, though, its roots go much deeper - both scientifically and into the North Carolina Piedmont - than might be obvious at first glance. Talecris was formed when two private investment firms provided the capital to …
https://www.bloomberg.com/profile/company/TLCR:US
Company profile page for Talecris Biotherapeutics Holdings Corp including stock price, company news, press releases, executives, board members, and contact information
https://www.chamberofcommerce.com/united-states/new-york/melville/biotechnology-company/33836238-talecris-biotherapeutics
Talecris Biotherapeutics is located at 155 Duryea Rd in Melville, New York 11747. Talecris Biotherapeutics can be contacted via phone at (631) 752-7314 for pricing, hours and directions.
https://www.grifols.com/en/view-news/-/news/grifols_acuerda_la_compra_de_talecris_biotherapeutics_para_consolidar_su_liderazg
Grifols (GRF.MC) a global healthcare company and leading producer of plasma protein therapies, and Talecris (NASDAQ: TLCR) a U.S.-based biotherapeutics products company, today announced that they have signed a definitive agreement through which Grifols will acquire Talecris for a combination of cash and newly issued Grifols non-voting shares having an …
https://www.dnb.com/business-directory/company-profiles.talecris_plasma_resources_inc.47a0162c16f0ad54820cd6272a8d773e.html
Find company research, competitor information, contact details & financial data for Talecris Plasma Resources, Inc. of Los Angeles, CA. Get the latest business insights from …
https://www.ftc.gov/legal-library/browse/cases-proceedings/1010153-grifols-sa-talecris-biotherapeutics-holdings-corp-matter
The FTC required Grifols, S.A., a manufacturer of plasma-derived drugs, to make significant divestitures as part of a settlement allowing Grifols to acquire a leading plasma-derived drug manufacturer, Talecris Biotherapeutics Holdings Corp. It resolves FTC charges that Grifols’ proposed acquisition of Talecris would be anticompetitive and would violate federal …
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Hauptsitz Von Talecris Biotherapeutics gefunden haben.
